REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
8.19
-0.32 (-3.76%)
Aug 1, 2025, 4:00 PM - Market closed
Activision Blizzard Market Cap
REGENXBIO has a market cap or net worth of $412.68 million as of August 1, 2025. Its market cap has decreased by -38.21% in one year.
Market Cap
412.68M
Enterprise Value
273.48M
1-Year Change
-38.21%
Ranking
Category
Stock Price
$8.19
Market Cap Chart
Since September 17, 2015, REGENXBIO's market cap has decreased from $749.30M to $412.68M, a decrease of -44.92%. That is a compound annual growth rate of -5.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 426.90M | 11.46% |
| Dec 31, 2024 | 383.00M | -51.50% |
| Dec 29, 2023 | 789.70M | -19.57% |
| Dec 30, 2022 | 981.90M | -29.79% |
| Dec 31, 2021 | 1.40B | -17.57% |
| Dec 31, 2020 | 1.70B | 12.32% |
| Dec 31, 2019 | 1.51B | 0.48% |
| Dec 31, 2018 | 1.50B | 45.18% |
| Dec 29, 2017 | 1.04B | 110.87% |
| Dec 30, 2016 | 491.10M | 12.43% |
| Dec 31, 2015 | 436.80M | -41.71% |
| Sep 17, 2015 | 749.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 683.63B |
| Johnson & Johnson | 401.04B |
| AbbVie | 344.48B |
| AstraZeneca | 236.88B |
| UnitedHealth Group | 230.18B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 223.17B |
| Novo Nordisk | 221.96B |